Literature DB >> 14243856

TUMORS OF THE BRAIN.

W E STERN.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG THERAPY; NEOPLASM DIAGNOSIS; NEOPLASM RADIOTHERAPY; REVIEW

Mesh:

Substances:

Year:  1965        PMID: 14243856      PMCID: PMC1515716     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


× No keyword cloud information.
  23 in total

1.  Stereotaxic yttrium-90 hypophysectomy for metastatic mammary carcinoma.

Authors:  R W RAND; A M DASHE; D H SOLOMON; J L WESTOVER; P H CRANDALL; J BROWN; R TRANQUADA
Journal:  Ann Surg       Date:  1962-12       Impact factor: 12.969

2.  Acoustic neurinomas: a follow-up.

Authors:  W J GERMAN
Journal:  Clin Neurosurg       Date:  1959

3.  Cranial dermoid and epidermoid tumors.

Authors:  J F R FLEMING; E H BOTTERELL
Journal:  Surg Gynecol Obstet       Date:  1959-10

4.  Glioblastoma multiforme: a clinical survey.

Authors:  J G ROTH; A R ELVIDGE
Journal:  J Neurosurg       Date:  1960-07       Impact factor: 5.115

5.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

6.  The surgical application of freeze-dried homologous dura mater.

Authors:  W E STERN
Journal:  Surg Gynecol Obstet       Date:  1958-02

7.  A study of the results of surgical treatment in 2,326 consecutive patients with brain tumor.

Authors:  F C GRANT
Journal:  J Neurosurg       Date:  1956-09       Impact factor: 5.115

8.  Tumors of the posterior portion of the third ventricle.

Authors:  R W RAND; L J LEMMEN
Journal:  J Neurosurg       Date:  1953-01       Impact factor: 5.115

9.  Cerebellar hemangioma (hemangioblastoma); a clinicopathological review of 40 cases.

Authors:  M L SILVER; G HENNIGAR
Journal:  J Neurosurg       Date:  1952-09       Impact factor: 5.115

10.  Chemotherapy of brain tumors by intra-arterial infusion.

Authors:  D M PERESE; C E DAY; W M CHARDACH
Journal:  J Neurosurg       Date:  1962-03       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.